ATE212229T1 - Bismut und antimikrobielle mittel enthaltende zusammensetzung zur verhütung und behandlung gastrointestinaler beschwerden - Google Patents

Bismut und antimikrobielle mittel enthaltende zusammensetzung zur verhütung und behandlung gastrointestinaler beschwerden

Info

Publication number
ATE212229T1
ATE212229T1 AT96940570T AT96940570T ATE212229T1 AT E212229 T1 ATE212229 T1 AT E212229T1 AT 96940570 T AT96940570 T AT 96940570T AT 96940570 T AT96940570 T AT 96940570T AT E212229 T1 ATE212229 T1 AT E212229T1
Authority
AT
Austria
Prior art keywords
prevention
treatment
composition containing
antimicrobial agents
gastrointestinal diseases
Prior art date
Application number
AT96940570T
Other languages
English (en)
Inventor
Jamesina Anne Fitzgerald
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Application granted granted Critical
Publication of ATE212229T1 publication Critical patent/ATE212229T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/429Thiazoles condensed with heterocyclic ring systems
    • A61K31/43Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/245Bismuth; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT96940570T 1995-12-07 1996-11-22 Bismut und antimikrobielle mittel enthaltende zusammensetzung zur verhütung und behandlung gastrointestinaler beschwerden ATE212229T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/569,033 US6051604A (en) 1995-12-07 1995-12-07 Methods and compositions for the prevention and treatment of gastrointestinal disorders
PCT/US1996/018654 WO1997020567A1 (en) 1995-12-07 1996-11-22 Compositions, comprising bismuth and one or more antimicrobials, for the prevention and treatment of gastrointestinal disorders

Publications (1)

Publication Number Publication Date
ATE212229T1 true ATE212229T1 (de) 2002-02-15

Family

ID=24273820

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96940570T ATE212229T1 (de) 1995-12-07 1996-11-22 Bismut und antimikrobielle mittel enthaltende zusammensetzung zur verhütung und behandlung gastrointestinaler beschwerden

Country Status (18)

Country Link
US (1) US6051604A (de)
EP (1) EP0865286B1 (de)
AT (1) ATE212229T1 (de)
BR (1) BR9611912A (de)
CA (1) CA2239420C (de)
CO (1) CO4790098A1 (de)
DE (1) DE69618813T2 (de)
DK (1) DK0865286T3 (de)
ES (1) ES2166912T3 (de)
IL (1) IL124730A (de)
MX (1) MX9804578A (de)
MY (1) MY127662A (de)
NO (1) NO982634L (de)
PE (1) PE37498A1 (de)
PT (1) PT865286E (de)
TR (1) TR199801022T2 (de)
TW (1) TW586927B (de)
WO (1) WO1997020567A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6429211B1 (en) * 2000-05-23 2002-08-06 Bayer Corporation Praziquantel compounds for treating diseases due to Sarcocystis Neospora Toxoplasma and Isospora
BRPI1009199A2 (pt) 2009-03-17 2016-03-08 Concert Pharmaceuticals Inc compostos de pirazinoisoquinolina
EP4178558A4 (de) 2020-06-08 2024-09-04 Elevaid Therapeutics, Inc. Verwendung von atovaquon und proguanil zur behandlung von magen-darm-erkrankungen und entzündungen

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR962163A (de) * 1950-06-02
US4049817A (en) * 1972-08-14 1977-09-20 Sandoz Ltd. Synergistic compositions
US4514421A (en) * 1979-08-30 1985-04-30 Herschler R J Dietary and pharmaceutical uses of methylsulfonylmethane and compositions comprising it
EP0222834A4 (de) * 1985-04-18 1989-10-04 Borody Thomas J Behandlung von nichtulcerativer dyspepsia mit wismutsalzen.
US5256684A (en) * 1985-06-13 1993-10-26 The Procter & Gamble Company Methods and compositions for the treatment of gastrointestinal disorders
EP0206625B1 (de) * 1985-06-13 1992-09-30 Barry James Dr. Marshall Zusammensetzungen zur Behandlung von Magen-Darmstörungen
JPS63174926A (ja) * 1987-01-09 1988-07-19 Nitto Kasei Kk 家禽用抗コクシジウム剤
US5196205A (en) * 1987-10-12 1993-03-23 Borody Thomas J Method for treatment of gastro intestinal disorders
EP0375068A1 (de) * 1988-12-23 1990-06-27 Gist-Brocades N.V. Mischungen von Bismuth-Verbindungen und Tetracyclinen
US5221664A (en) * 1990-04-23 1993-06-22 Magainin Pharmaaceuticals Inc. Composition and treatment with biologically active peptides and toxic cations
ATE135227T1 (de) * 1990-07-20 1996-03-15 Slagel David Produkte und verfahren zur behandlung des verdauungskanals
DE59309771D1 (de) * 1993-05-11 1999-10-14 Spirig Ag Festes bismut- und amoxycillinhaltiges Arzneipräparat und seine Verwendung
AUPM596894A0 (en) * 1994-05-30 1994-06-23 Hybrid Scientific Pty Ltd Composition for treating gastrointestinal disorders - a combination of bismuth salts plus lactobacillus or bifidobacteria species bacteria for treating gastrointestinal disorders

Also Published As

Publication number Publication date
EP0865286B1 (de) 2002-01-23
TW586927B (en) 2004-05-11
NO982634D0 (no) 1998-06-08
DE69618813D1 (de) 2002-03-14
CO4790098A1 (es) 1999-05-31
PT865286E (pt) 2002-06-28
CA2239420A1 (en) 1997-06-12
MX9804578A (es) 1998-10-31
MY127662A (en) 2006-12-29
PE37498A1 (es) 1998-08-27
EP0865286A1 (de) 1998-09-23
WO1997020567A1 (en) 1997-06-12
ES2166912T3 (es) 2002-05-01
US6051604A (en) 2000-04-18
CA2239420C (en) 2003-03-18
BR9611912A (pt) 1999-04-06
DK0865286T3 (da) 2002-03-25
TR199801022T2 (xx) 1998-10-21
DE69618813T2 (de) 2002-10-02
NO982634L (no) 1998-08-04
IL124730A (en) 2003-07-31
IL124730A0 (en) 1999-01-26

Similar Documents

Publication Publication Date Title
DE69618813D1 (de) Bismut und antimikrobielle mittel enthaltende zusammensetzung zur verhütung und behandlung gastrointestinaler beschwerden
ATE231726T1 (de) Wismuth und eine oder mehrere antimikrobielle mittel enthaltende zusammensetzungen zur verhütung und behandlung gastrointestinaler beschwerden
ATE213637T1 (de) Bismut enthaltende zusammensetzungen zur verhütung und behandlung gastrointestinaler beschwerden
ATE211914T1 (de) Wismuth enthaltende zusammensetzungen zur verhütung und behandlung gastrointestinaler beschwerden

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee